Kumar, Abhijeet <br/><br/>
Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients.  [electronic resource] 

 -  Current treatment options in oncology  09 2018 
 - 50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1534-6277 
<br/><br/><label>Standard No.: </label>10.1007/s11864-018-0565-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Aged<br/>Aged, 80 and over<br/>Anthracyclines--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Brentuximab Vedotin<br/>Cyclophosphamide--adverse effects<br/>Doxorubicin--adverse effects<br/>Female<br/>Frail Elderly<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Immunotherapy--methods<br/>Lenalidomide--therapeutic use<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Piperidines<br/>Prednisone--adverse effects<br/>Pyrazoles--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Rituximab--therapeutic use<br/>Vincristine--adverse effects